Kathryn E. Packman

City:

Newton, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2023-11-30

Top Assignees for applications by Kathryn E. Packman

The entities that hold a legal rights for patent applications filed by inventor Packman Kathryn E.:

ROCHE GLYCART AG 2 Schlieren, Switzerland
Janssen Pharmaceutica NV 1 Beerse, Belgium
Hoffmann-La Roche Inc. 1 Nutley, NJ United States

Recent patent applications by Packman Kathryn E.

Kathryn E. Packman from Newton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-11-30

US20230381215A1

Human necessities

NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML)

#2 | 2023-01-19

US20230013755A1

Human necessities

INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE

#3 | 2022-02-03

US20220031726A1

Human necessities

NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML)

#4 | 2020-08-13

US20200253999A1

Human necessities

NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML)

#5 | 2019-02-28

US20190062453A1

Chemistry; metallurgy

Antibodies specific for DR5 and methods of use

#6 | 2016-10-20

US20160303158A1

Human necessities

NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML)

#7 | 2016-05-12

US20160129034A1

Human necessities

COMBINATION OF RO5503781, CAPECITABINE AND OXALIPLANTIN FOR CANCER THERAPY

#8 | 2016-05-12

US20160129033A1

Human necessities

COMBINATION OF RO5503781 AND CAPECITABINE FOR CANCER THERAPY

#9 | 2015-06-11

US20150157603A1

Human necessities

Combination treatment for acute myeloid leukemia (AML)

#10 | 2014-12-18

US20140370019A1

Chemistry; metallurgy

Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5

InventorID:

1006152 ⎘